New York Times News Service, New York.
Published by: Dev Kashyap
Updated Tue, 14 Sep 2021 03:54 AM IST
hear the news
Dr. Scott Gottlieb, former commissioner of the US Food and Drug Administration (FDA) and member of the Pfizer board, has said that a rapid review of clinical data will be necessary for vaccines for underage children to be approved. Gottlieb said on CBS’ “Face the Nation” program that in a best-case scenario, Pfizer’s vaccines will be ready for underage children by October 31. “I have confidence in the kind of data that Pfizer has collected,” he said. Dr. James Versalovic, interim chief of pediatrics at Texas Children’s Hospital, said he agreed with Gottlieb about the possibility of vaccines for underage children being approved by October. We are doing everything we can to take these trials forward, Dr. Versalovic said.
Very low risk of death in children
The report said that both Pfizer and Moderna companies are collecting data on the safety, correct dosage and effectiveness of the Kovid vaccine in children. According to the report, children suffering from Kovid are more likely to have mild symptoms or none at all compared to adults. Children are much less likely to develop serious illness, be hospitalized, or die from the disease.
22 new cases of infection in southeast China
In a province in southeast China, 22 new cases of Kovid-19 have been reported. A total of 43 new cases have been reported in the recent outbreak of infection due to the highly contagious delta form of the corona virus. Health officials said on Monday that in the past 24 hours, 15 cases of infection have been reported in Putian city, six in Quanzhou city and one case in Xiamen, indicating that the virus is also spreading to the south. All the cases of infection are in Fujian province.
#Relief #Vaccine #children #years #month #fears #wave